Aprepitant for Erlotinib-Induced Pruritus
Aprepitant for Erlotinib-Induced Pruritus
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Aprepitant is the first commercially available drug of a new class of neurokinin-1–receptor antagonists for treating chemotherapy-induced nausea and vomiting. The dominant ligand for the neurokinin-1 receptor is substance P.
1
,
2
An increase in the number of neurokinin-1 receptors on keratinocytes has been found in pa...
Alternative Titles
Full title
Aprepitant for Erlotinib-Induced Pruritus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_646905640
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_646905640
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1003937
